Cholesterol synthesis inhibitors protect against platelet-activating factor-induced neuronal damage
<p>Abstract</p> <p>Background</p> <p>Platelet-activating factor (PAF) is implicated in the neuronal damage that accompanies ischemia, prion disease and Alzheimer's disease (AD). Since some epidemiological studies demonstrate that statins, drugs that reduce choleste...
Main Authors: | Williams Alun, Rumbold Louis, Bate Clive |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-01-01
|
Series: | Journal of Neuroinflammation |
Online Access: | http://www.jneuroinflammation.com/content/4/1/5 |
Similar Items
-
cAMP-Inhibits Cytoplasmic Phospholipase A2 and Protects Neurons against Amyloid-β-Induced Synapse Damage
by: Clive Bate, et al.
Published: (2015-09-01) -
α-Synuclein-Induced Synapse Damage in Cultured Neurons Is Mediated by Cholesterol-Sensitive Activation of Cytoplasmic Phospholipase A2
by: Clive Bate, et al.
Published: (2015-03-01) -
Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures
by: Clive Bate, et al.
Published: (2018-03-01) -
Ginkgolides protect against amyloid-β<sub>1–42</sub>-mediated synapse damage <it>in vitro</it>
by: Williams Alun, et al.
Published: (2008-01-01) -
Phospholipase A<sub>2 </sub>inhibitors protect against prion and Aβ mediated synapse degeneration
by: Williams Alun, et al.
Published: (2010-04-01)